久久99视频精品8,永久久久精品人人做人人爽,久久av在线影院

AQ-13 dihydrochloride

NMR下載 COA and HPLC MSDS下載
names：
AQ-13 dihydrochloride
CAS號：
169815-40-1
MDL Number： No data available
MF(分子式)： C16H24Cl3N3 MW(分子量)： 364.74
EINECS:No data available Reaxys Number:No data available
Pubchem ID:9820475 Brand:BIOFOUNT

AQ-13 dihydrochloride(169815-40-1) 是一種能有效對抗惡性瘧原蟲 (Plasmodium falciparum) 的抗氯喹l抗瘧產品。

貨品編碼	規格	純度	價格 (￥)	現價(￥)	特價(￥)	庫存描述	數量	總計 (￥)
YZM000856-10mg	10mg	98%	￥ 1560.00	￥ 1560.00		2-3天	- +	￥ 0.00
YZM000856-5mg	5mg	98%	￥ 880.00	￥ 880.00		2-3天	- +	￥ 0.00

大包裝詢價提供各種包裝，敬請垂詢
收藏商品商品點評加入購物車立即購買

快速詢價

收起

你想詢價的產品

*產品名稱：

CAS號：

產品編號：

需求描述：

請準確填寫您的聯系方式，以便為您提供最好的服務。

*公司名稱：

*電子郵箱：

聯系人：

*電話：

*驗證碼：

詢價

中文別名	AQ-13 dihydrochloride(169815-40-1);N'-(7-氯-4-喹啉基)-N,N-二乙基-1,3-丙二胺二鹽酸鹽
英文別名	AQ-13 dihydrochloride,169815-40-1;AQ-13;AQ 13
CAS號	169815-40-1
Inchi	InChI=1S/C16H22ClN3.2ClH/c1-3-20(4-2)11-5-9-18-15-8-10-19-16-12-13(17)6-7-14(15)16;;/h6-8,10,12H,3-5,9,11H2,1-2H3,(H,18,19);2*1H
InchiKey	ZNHBPWZRWNFJPN-UHFFFAOYSA-N
分子式 Formula	C16H24Cl3N3
分子量 Molecular Weight	364.74
溶解度Solubility	生物體外In Vitro:DMSO溶解度80 mg/mL(219.33 mM;Need ultrasonic)
性狀	淺黃色至黃色固體粉末
儲藏條件 Storage conditions	-20°C 3 years年 4°C 2 years年 / 溶液中:-80°C 6 months月 -20°C 1 month月

AQ-13 dihydrochloride(169815-40-1)實驗注意事項：
1.實驗前需戴好防護眼鏡，穿戴防護服和口罩，佩戴手套，避免與皮膚接觸。
2.實驗過程中如遇到有毒或者刺激性物質及有害物質產生，必要時實驗操作需要手套箱內完成以免對實驗人員造成傷害
3.實驗后產生的廢棄物需分類存儲，并交于專業生物廢氣物處理公司處理，以免造成環境污染

AQ-13 dihydrochloride(169815-40-1) Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.

Tag:AQ-13 dihydrochloride(169815-40-1),AQ-13 dihydrochloride試劑,AQ-13 dihydrochloride的作用,AQ-13 dihydrochloride抑制劑,AQ-13 dihydrochloride的合成,AQ-13 dihydrochloride的廠家,AQ-13 dihydrochloride的生產,AQ-13 dihydrochloride的價格

產品說明	AQ-13 dihydrochloride(169815-40-1) 是一種能有效對抗惡性瘧原蟲 (Plasmodium falciparum) 的抗氯喹l抗瘧產品。
Introduction	AQ-13 dihydrochloride(169815-40-1) is an aminoquinoline antimalarial drug that is effective against chloroquineesistant strains of Plasmodium falciparum.
Application1
Application2
Application3

警示圖
危險性	warning
危險性警示	Not available
安全聲明	H303吞入可能有害+H313皮膚接觸可能有害+H2413吸入可能對身體有害
安全防護	P264處理后徹底清洗+P280戴防護手套/穿防護服/戴防護眼罩/戴防護面具+P305如果進入眼睛+P351用水小心沖洗幾分鐘+P338取出隱形眼鏡（如果有）并且易于操作,繼續沖洗+P337如果眼睛刺激持續+P2393獲得醫療建議/護理
備注	實驗過程中防止吸入、食入，做好安全防護

Sensitive fluorescence HPLC assay for AQ-13, a candidate aminoquinoline antimalarial, that also detects chloroquine and N-dealkylated metabolites

Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers

Genetic toxicology testing of the antimalarial drugs chloroquine and a new analog, AQ-13

Genetic toxicology testing of the antimalarial drugs chloroquine and a new analog, AQ-13
Abstract:AQ-13 ([N1-(7-chloro-quinolin-4yl)-3-(N3,N3-diethylamino)propylamine] dihydrochloride trihydrate) is an aminoquinoline antimalarial drug that is effective against chloroquine-resistant strains of Plasmodium falciparum. It is structurally similar to the widely used chloroquine diphosphate (CQ). We evaluated these drugs in the three assays currently recommended by the International Conference on Harmonization (ICH): bacterial mutagenesis in Salmonella typhimurium and Escherichia coli, mammalian cell mutagenesis in L5178Y mouse lymphoma cells, and micronucleus induction in rat bone marrow. A small but statistically significant increase in revertant colonies was produced by CQ with Salmonella tester strain TA98 without metabolic activation (MA) and by AQ-13 with strain TA1537 both with and without MA. In L5178Y cells, testing of CQ and AQ-13 up to cytotoxic concentrations with and without MA produced no increase in mutant colonies and no increase in the numbers of small colonies. Slight decreases in the ratio of polychromatic erythrocytes (PCE) to red blood cells (RBC) were observed in male and female rats treated with CQ and in females only treated with AQ-13; however, none of these changes was statistically significant. No increases in the frequency of micronucleated PCE were observed at any dose level of CQ or AQ-13. Although both CQ and AQ-13 showed weak bacterial mutagenicity, this mutagenic effect was not confirmed in either the mouse lymphoma mutagenesis assay or the micronucleus assay. These results indicate that CQ and AQ-13 should pose minimal risk of genotoxic damage in human populations being administered these drugs.

對不起，暫無產品評價！

MSDS

SDS 1.0 中文

展開

SDS 1.0 英文

展開